Page 7,038«..1020..7,0377,0387,0397,040..7,0507,060..»

InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on St. Louis’ Fox 2 News in the Morning

Posted: Published on March 7th, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds is scheduled to appear on KTVI-TVs Fox 2 News in the Morning at 7:40 am CDT on Monday, March 12th in St. Louis, MO. InVivo Therapeutics has pioneered a new treatment platform that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to spare tissue from scarring while improving recovery and prognosis after a traumatic spinal cord injury. Reynolds will discuss the scaffold and how it is expected to work in humans, as well as results from InVivos largest non-human primate study. We expect that our technology will change the standard care for spinal cord injury treatment. Were currently under review at FDA and we look forward to receiving approval to begin human studies, said Reynolds. Our therapeutic approach confirms a clear paradigm shift in the treatment of spinal cord injuries. Fox 2 News in the Morning is the morning show for KTVI-TV, the FOX affiliate for the St. Louis market. About InVivo Therapeutics InVivo Therapeutics Holdings Corp. is utilizing polymers as a platform technology … Continue reading

Posted in Spinal Cord Injury Treatment | Comments Off on InVivo Therapeutics’ CEO Frank Reynolds Scheduled to Appear on St. Louis’ Fox 2 News in the Morning

New research characterizes glaucoma as neurologic disorder rather than eye disease

Posted: Published on March 7th, 2012

Public release date: 6-Mar-2012 [ | E-mail | Share ] Contact: Mary Wade mwade@aao.org 415-447-0221 American Academy of Ophthalmology SAN FRANCISCO March 6, 2012 A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, the journal of the American Academy of Ophthalmology, reports that some top researchers no longer think of glaucoma solely as an eye disease. Instead, they view it as a neurologic disorder that causes nerve cells in the brain to degenerate and die, similar to what occurs in Parkinson disease and in Alzheimer's. The review, led by Jeffrey L Goldberg, M.D., Ph.D., assistant professor of ophthalmology at the Bascom Palmer Eye Institute and Interdisciplinary Stem Cell Institute, describes treatment advances that are either being tested in patients or are scheduled to begin clinical trials soon. Glaucoma is the most common cause of irreversible blindness worldwide. For many years, the prevailing theory was that vision damage in glaucoma patients was caused by abnormally high pressure inside the eye, known as intraocular pressure (IOP). As a result, lowering IOP was the only goal of … Continue reading

Posted in Parkinson's Treatment | Comments Off on New research characterizes glaucoma as neurologic disorder rather than eye disease

Public invited to Parkinson's disease forum

Posted: Published on March 7th, 2012

Public invited to Parkinsons disease forum Free event set for Saturday in Sun Valley By REBECCA MEANY Express Staff Writer Parkinson's disease experts will be in Sun Valley on Saturday, March 10, for a free, informational public seminar. As part of the Parkinson's Disease Education Series, sponsored by the University of Utah Health Care Clinical Neurosciences Center, the seminar this Saturday will update attendees on research, treatment and clinical care for Parkinson's disease sufferers, their families and health care providers. Speakers will be Dr. Lauren Schrock and Dr. David Shprecher from the University of Utah and Dr. Kenneth Brait from St. Luke's Hailey Clinic. The presenters will provide updates on how Parkinson's disease and related disorders are diagnosed and managed. "Just as drug therapy transformed the treatment of Parkinson's disease 40 years ago, new techniques of electronic treatment to the brain by way of deep brain stimulation are extending the productive years of Parkinson's patients," Brait said. "We will be discussing the interplay between the pharmacologic and electronic therapies." Shprecher said the group will highlight ongoing research, including their own, designed to advance treatment of Parkinson's disease. A question-and-answer session will follow their presentations. Read the original: Public invited to … Continue reading

Posted in Parkinson's Treatment | Comments Off on Public invited to Parkinson's disease forum

Ontario brains put their heads together

Posted: Published on March 7th, 2012

Theres much excitement in the scientific world over three Ontario Brain Institute projects expected to make new discoveries in treating autism, epilepsy and cerebral palsy. Were going after the brass ring, explains Dr. Peter Szatmari about the significance of the research to be done. Szatmari is director of the Offord Centre for Child Studies in Hamilton, head of psychiatry at McMaster Childrens Hospital and a McMaster University psychiatry and behavioural neuroscience professor. He is also one of five lead researchers in the Institutes project on finding better treatments for neurodevelopment disorders. Szatmari said he wont use the word cure, but he does expect great things, and at the very least, vast improvements to be found in treating children suffering from Autism Spectrum Disorders and others disorders such as Attention Deficit Hyperactivity and Obsessive Compulsive. Were now at the stage where we think we can make significant advancements in treatment, said Szatmari, who has studied autism disorders for 30 years. Ive been in this game a long time, so Im excited to work with not only McMaster researchers but new colleagues and scientists from across Ontario. Its a novel approach of everyone working together for the common goal of reducing the … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Ontario brains put their heads together

Birth Injuries from Medical Malpractice Can Create a Lifetime of Financial and Emotional Challenges for Victims and …

Posted: Published on March 7th, 2012

The Law Offices of Dr. Bruce G. Fagel & Associates understands that a birth injury can be one of the most devastating events that can happen to a family. Brain injuries are the most serious type of birth injuries. Sometimes these injuries occur not by nature, but as a result of medical negligence. A lack of communication between doctors and nurses, failure to properly monitor a fetal heart rate monitor, or failing to perform a C-Section when necessary, could result in brain damage or Cerebral palsy. Los Angeles, CA (PRWEB) March 06, 2012 What most people fail to understand with a severe birth injury is how much the medical costs will be for a family to care for their child. If their child has cerebral palsy for example, this can cost upwards of millions of dollars for the proper care and treatment, states Bruce Fagel. Dr. Fagel has seen the costs of caring for severely injured children rise dramatically during the past decade. Medical malpractice and birth injuries can occur from lack of blood flow or oxygen to the brain, trauma, or infection. Hospitals use a fetal heart rate monitor, which monitors the condition of the babys heart rate during … Continue reading

Posted in Cerebral Palsy Treatment | Comments Off on Birth Injuries from Medical Malpractice Can Create a Lifetime of Financial and Emotional Challenges for Victims and …

Health: New Treatment Could Prevent Severe Disabilities In Trauma Patients

Posted: Published on March 7th, 2012

By Stephanie Stahl PHILaDELPHIA (CBS) Traumatic brain injuries are often fatal or leave people with severe disabilities. Now a breakthrough treatment is being tested here in Philadelphia that could change everything. 3 On Your Side Health Reporter speaks with a patient who wasnt expect to survive. It was the worst kind of accident, a motorcycle crash. He wasnt wearing a helmet, and suffered a catastrophic brain injury. It was heart breaking. It was tough, said Anna Huffman, whos husband Roger was in the accident this past October. Doctors said he was close to death. If he survived he could be severely disabled. If it was paralyzed or death, Id take the death, said Roger. There were weeks of uncertainty, and desperation for the Pottsgrove couple whove been married 46 years. When I was in the hospital I had a love hate relationship with her. I love seeing her coming to the hospital to see me. Oh God did I hate to see her leave, said Roger. There are no more painful goodbyes. 65-year-old Roger beat the odds and is fine now, except for being a little more emotional than usual. His remarkable recovery might be because of a new experimental … Continue reading

Posted in Brain Injury Treatment | Comments Off on Health: New Treatment Could Prevent Severe Disabilities In Trauma Patients

Irreversible Catastrophic Brain Hemorrhaging Following Minor Brain Injury in a Patient Taking Dabigatran

Posted: Published on March 7th, 2012

Newswise Charlottesville, Va.; and Rolling Meadows, Ill. Clinicians from the University of Utah report the death of a patient who received a mild brain injury from a ground-level fall while taking the new anticoagulant dabigatran etexilate for nonvalve related atrial fibrillation. The authors describe the events that led from a mild traumatic brain injury to the mans death, the largely irreversible dangers of massive hemorrhage from direct thrombin inhibitors such as dabigatran, and the few management options that can be used to counteract this uncontrollable bleeding. Their findings and suggestions can be found in the article Neurosurgical complications of direct thrombin inhibitorscatastrophic hemorrhage after mild traumatic brain injury in a patient receiving dabigatran. Case report, by Drs. Sarah Garber, Walavan Sivakumar, and Richard Schmidt, published online March 6 in the Journal of Neurosurgery (click here to see the case report). The take-away message is that bleeding complications associated with direct thrombin inhibitors, such as dabigatran, are largely irreversible. Physicians should suspect the strong potential for catastrophic hemorrhage in patients taking these medications so that available, albeit limited, management options can be put into effect without delay. Dabigatran etexilate (Pradaxa) is an oral anticoagulant (blood thinner) recently approved by the US … Continue reading

Posted in Brain Injury Treatment | Comments Off on Irreversible Catastrophic Brain Hemorrhaging Following Minor Brain Injury in a Patient Taking Dabigatran

Brain-injured urged to seek treatment

Posted: Published on March 7th, 2012

By Drew Brooks Staff writer The explosion and the months that followed are still a blur to Sgt. Maj. Richard Steele, but the effects of the blast on his brain still linger. The Special Forces soldier was in a vehicle hit by insurgents in Timagara, Pakistan, on Feb. 3, 2010. The attack left Steele with traumatic brain injury. But like many other soldiers with similar injuries, he hid the symptoms so he could return to duty sooner, despite the short-term memory loss, headaches and dizziness. Steele shared his story at Womack Army Medical Center on Tuesday, speaking at a program to raise awareness of traumatic brain injuries within the military. March is Brain Injury Awareness Month in the Army. Maj. Gen. Richard Stone, the Army's deputy surgeon general, and Brig. Gen. Christian Juneau, a Fort Bragg deputy commanding general, also spoke. Stone said he came to the "center of Army combat power" to spread the message that traumatic brain injuries are serious. Too often, he said, soldiers try to hide the signs of brain injuries to get back to work - a dangerous practice that only puts them at greater risk. Stone said the number of such injuries reported by … Continue reading

Posted in Brain Injury Treatment | Comments Off on Brain-injured urged to seek treatment

Traumatic brain injury focus of two-day conference in ND

Posted: Published on March 7th, 2012

A traumatic brain injury can happen at anytime, anywhere, and to anyone. The Mind Matters 2012 Brain Injury Conference on March 7-8, 2012, at the Radisson Hotel in Bismarck, aims to educate medical and other treatment professionals, veterans, brain injury survivors and their family members, and others about the prevalence and effects of brain injury and the recovery process. An entire day will be dedicated to traumatic brain injury issues facing men and woman serving in the armed forces. A brain injury can have a dramatic impact on a persons life, as well as the lives of family and friends, said Richard Ott, executive director of Head Injury Association of North Dakota. This conference offers dialogue from a variety of perspectives to better understand brain injuries and their long-lasting effects. The morning keynote presentation on March 7 features Harvey Jacobs, Ph.D., a psychologist and behavior analyst, who will provide an in-depth look at behavioral changes caused by traumatic brain injuries. Afternoon presentations include recognizing the causes, consequences, and challenges traumatic brain injuries have on individuals, families and communities, long-term rehabilitation, pain control, transition planning for community living, and more. There will also be a panel discussion featuring three people living … Continue reading

Posted in Brain Injury Treatment | Comments Off on Traumatic brain injury focus of two-day conference in ND

MS drug Gilenya loses market share

Posted: Published on March 7th, 2012

Daniel Acker / Bloomberg Pump prices have slipped less than a penny a gallon. Novartis AG's Gilenya multiple sclerosis pill lost market share for the first time in January, following the deaths of some patients soon after taking the first pill available for the disease in the United States. Gilenya's share of the U.S. market for so-called immunomodulatory drugs against MS fell to 6.1 percent from 6.2 percent in December, according to data from Wolters Kluwer NV, a market research company. The decline was the first after 15 months of growth, at a median of 15 percent a month, since the treatment received U.S. regulatory approval in September 2010. The Food and Drug Administration and the European Medicines Agency are investigating 11 deaths among Gilenya patients. In the past month, analysts have cut their forecasts for peak sales of Gilenya by 10 percent to $2.1 billion in 2016, according to the average of six estimates compiled by Bloomberg. The deaths have "made me a little more cautious," said Aaron Miller, chief medical officer of the U.S. National Multiple Sclerosis Society, and a medical director at Mount Sinai Hospital in New York. "I am not somebody who has recommended Gilenya as … Continue reading

Posted in MS Treatment | Comments Off on MS drug Gilenya loses market share

Page 7,038«..1020..7,0377,0387,0397,040..7,0507,060..»